MIR548AY

Across TCGA pan-cancer cohorts, MIR548AY RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR548AY data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR548AY RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548AY expression acts as an unfavorable survival marker, although some lineages such as PAAD show a favorable association.

MESO, UVM, and BRCA are the cancer types where MIR548AY RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	IV	0.056	0.640	<.001	63	view →
UVM	DFS	Tertile	All	0.289	0.775	.018	36	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
ESCA	DFS	Tertile	II,III,IV	0.131	0.776	.043	15	view →
COAD	OS	Tertile	II,III,IV	0.628	0.861	.007	15	view →
LIHC	OS	Tertile	All	0.557	0.697	.017	15	view →
THYM	DFS	Tertile	II,III,IV	0.145	0.873	<.001	12	view →
PAAD	OS	Tertile	All	0.710	0.291	.020	9	view →
LGG	DFS	Tertile	All	0.755	0.852	.007	9	view →
SKCM	DFS	Tertile	All	0.625	0.735	.021	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR548AY–MESO (OS)

Open the MESO breakdown →